Literature DB >> 18981857

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

Moneeb Ehtesham, Charles B Stevenson, Reid C Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18981857     DOI： 10.1227/01.NEU.0000325687.45344.9E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  4 in total

1.  The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

Authors:  M Fareh; L Turchi; V Virolle; D Debruyne; F Almairac; S de-la-Forest Divonne; P Paquis; O Preynat-Seauve; K-H Krause; H Chneiweiss; T Virolle
Journal:  Cell Death Differ       Date:  2011-07-01       Impact factor: 15.828

Review 2.  The role of the CXCR4 cell surface chemokine receptor in glioma biology.

Authors:  Moneeb Ehtesham; Elliot Min; Neil M Issar; Rebecca A Kasl; Imad S Khan; Reid C Thompson
Journal:  J Neurooncol       Date:  2013-03-14       Impact factor: 4.130

3.  A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Authors:  Laura M Shelton; Purna Mukherjee; Leanne C Huysentruyt; Ivan Urits; Joshua A Rosenberg; Thomas N Seyfried
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

4.  CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats.

Authors:  Briana Mason; Corey Calhoun; Victoria Woytowicz; Latifa Pina; Roshninder Kanda; Curtis Dunn; Antonio Alves; S Tiffany Donaldson
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.